维普中文期刊产品整合服务
18篇 您的检索式:作者名="Wensing AM"
    题名 作者 年代 出处 被引量
1Prevalence of drug-resistant HIV-1 variants in untreated individuals in Eu- rope: implications for clinical management显示文摘Wensing AM van de Vijver DA Angarano G 2005J Infect Dis2005,192,6:1
2Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management 显示文摘Wensing AM Van de Vijver DA Angarano G 2005J Infect Dis2005,192,6:1
3Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management 显示文摘Wensing AM Van de Vijver DA Angarano G 2005J Infec Dis2005,192,6:1
4Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications forclinical management 显示文摘Wensing AM van de \jver DA Angarano G 2005J Infect Dis2005,192,6:1
5Dependence on theCCR5 coreceptor for viral replication explains the lack ofrebound of CXCR4-predicted HIV variants in the Berlinpatient 显示文摘Symons J Vandekerckhove L Hutter G Wensing AM van Ham PM Deeks SG Nijhuis M 2014Clin Infect Dis2014,59,4:1
6European guidelines on the clinical management of HIV-1 tropism testing 显示文摘Vandekerckhove LP Wensing AM Kaiser R 2011Lancet Infect Dis2011,11,5:1
7Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management显示文摘Wensing AM Van De Vijver DA Angarano G 2005J Infect Dis2005,192,6:1
8Worldwide transmission of drug-re-sistant HIV显示文摘Wensing AM Boucher C 2005AIDS2005,19,2:1
9Prevention of mother-to-child transmission of multi-drug resistant HIV-1 using maternal therapy with both enfuvirtide and tipranavir 显示文摘Wensing AM Boucher CA van Kasteren M van Dijken PJ Geelen SP Juttmann JR 2006AIDS2006,20,10:1
10Fif- teen years of HIV Protease Inhibitors: raising the barrier to resistance 显示文摘Wensing AM van Maarseveen NM Nijhuis M 2010Antiviral Res2010,85,1:1
11HIV protease inhibitors显示文摘Wensing AM van Maarseveen NM Nijhuis M 0,,:1
12Fifteen years of HIV protease inhibitors: raising the barrier to resistance 显示文摘Wensing AM van Maarseveen NM Nijhuis M 2010Antiviral Res2010,85,:1
13Analysis of the world-wide evaluation study on HIV-1 genotype interpretation;ENVA-3显示文摘Wensing AM Keulen W Buimer M 2001Antivir Ther2001,6,1:1
14Transmission of drug-resistant HIV-1is stabilizing in Europe显示文摘Vercauteren J Wensing AM van de Vijver DA 2009J Infect Dis2009,200,10:1
15Dependence on theCCR5 coreceptor for viral replication explains the lack ofrebound of CXCR4-predicted HIV variants in the Berlinpatient 显示文摘Symons J Vandekerckhove L Hiitter G Wensing AM van Ham PM Deeks SG Nijhuis M 2014Clin Infect Dis2014,59,4:1
16Worldwide transmission ofdrug-resistant HIV 显示文摘Wensing AM Boucher CA 2003AIDS Rev2003,5,3:1
17Prevalence of drug- resistant HIV - 1 variants in untreated individuals in Eu- rope : implications for clinical management 显示文摘Wensing AM van de Vijver DA Angarano G 2005J Infect Dis2005,192,6:1
18Worldwide transmission of drug-resistant HIV显示文摘 Boucher CA 2003AIDS Rev2003,5,3:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费